{"id":"https://openalex.org/W7223093377","doi":"https://doi.org/10.64898/2026.10.16.26365646","title":"PBPK Model-Based Prediction of Optimal Rosuvastatin Dosing with Concomitant Ticagrelor in Elderly Patients Considering ABCG2 Genetic Variant","display_name":"PBPK Model-Based Prediction of Optimal Rosuvastatin Dosing with Concomitant Ticagrelor in Elderly Patients Considering ABCG2 Genetic Variant","publication_year":2026,"publication_date":"2026-10-21","ids":{"openalex":"https://openalex.org/W7223093377","doi":"https://doi.org/10.64898/2026.10.16.26365646"},"language":"en","primary_location":{"id":"doi:10.64898/2026.10.16.26365646","doi":"https://doi.org/10.64898/2026.10.16.26365646","is_oa":true,"landing_page_url":"https://doi.org/10.64898/2026.10.16.26365646","pdf_url":"https://www.medrxiv.org/content/medrxiv/early/2026/10/21/2026.10.16.26365646.full.pdf","source":{"id":"https://openalex.org/S3005729997","display_name":"medRxiv","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":["https://openalex.org/P4310315909"],"host_organization_lineage_names":["Cold Spring Harbor Laboratory Press"],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"medRxiv","raw_type":"posted-content"},"volume":null,"type":"preprint","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.medrxiv.org/content/medrxiv/early/2026/10/21/2026.10.16.26365646.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5159184355","display_name":"Dat Hoang Nguyen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I25399158","display_name":"Mahidol University","ror":"https://ror.org/01znkr924","country_code":"TH","type":"education","lineage":["https://openalex.org/I25399158"]}],"countries":["TH"],"is_corresponding":false,"raw_author_name":"Hoang Dat Nguyen","raw_affiliation_strings":["Master of Science Program in Biopharmaceutical Sciences, Department of Biochemistry, Faculty of Pharmacy, Mahidol University, Bangkok 10400, Thailand"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Master of Science Program in Biopharmaceutical Sciences, Department of Biochemistry, Faculty of Pharmacy, Mahidol University, Bangkok 10400, Thailand","institution_ids":["https://openalex.org/I25399158"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5159214522","display_name":"Hoa Thi Vinh Pham","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210160954","display_name":"Animal and Plant Quarantine Agency","ror":"https://ror.org/04sbe6g90","country_code":"KR","type":"government","lineage":["https://openalex.org/I4210160954"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Vinh Hoa Pham","raw_affiliation_strings":["Bacterial Disease Division, Department of Animal and Plant Health Research, Animal and Plant Quarantine Agency, 39660 Gimcheon, Republic of Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bacterial Disease Division, Department of Animal and Plant Health Research, Animal and Plant Quarantine Agency, 39660 Gimcheon, Republic of Korea","institution_ids":["https://openalex.org/I4210160954"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5159213248","display_name":"Junje Ding","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I25399158","display_name":"Mahidol University","ror":"https://ror.org/01znkr924","country_code":"TH","type":"education","lineage":["https://openalex.org/I25399158"]},{"id":"https://openalex.org/I4210126604","display_name":"Mahidol Oxford Tropical Medicine Research Unit","ror":"https://ror.org/03fs9z545","country_code":"TH","type":"facility","lineage":["https://openalex.org/I25399158","https://openalex.org/I40120149","https://openalex.org/I4210126604","https://openalex.org/I87048295"]}],"countries":["TH"],"is_corresponding":true,"raw_author_name":"Junjie Ding","raw_affiliation_strings":["Mahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand","institution_ids":["https://openalex.org/I25399158","https://openalex.org/I4210126604"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5090110810","display_name":"Joel T\u00e4rning","orcid":"https://orcid.org/0000-0003-4566-4030","observed_orcids":["https://orcid.org/0000-0003-4566-4030"]},"institutions":[{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]},{"id":"https://openalex.org/I4210155930","display_name":"Infectious Diseases Data Observatory","ror":"https://ror.org/04tp3cz81","country_code":"GB","type":"facility","lineage":["https://openalex.org/I4210155930"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Joel Tarning","raw_affiliation_strings":["Centre for Tropical Medicine and Global Health, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK","Infectious Diseases Data Observatory, University of Oxford, Oxford, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Tropical Medicine and Global Health, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK","institution_ids":["https://openalex.org/I40120149"]},{"raw_affiliation_string":"Infectious Diseases Data Observatory, University of Oxford, Oxford, UK","institution_ids":["https://openalex.org/I40120149","https://openalex.org/I4210155930"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5090110810","https://openalex.org/A5159213248"],"corresponding_institution_ids":["https://openalex.org/I25399158","https://openalex.org/I40120149","https://openalex.org/I4210126604","https://openalex.org/I4210155930"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9707000255584717,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9707000255584717,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.011900000274181366,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11064","display_name":"Antiplatelet Therapy and Cardiovascular Diseases","score":0.004399999976158142,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/rosuvastatin","display_name":"rosuvastatin","score":0.9990000128746033},{"id":"https://openalex.org/keywords/ticagrelor","display_name":"ticagrelor","score":1.0},{"id":"https://openalex.org/keywords/abcg2","display_name":"ABCG2","score":0.7839999794960022},{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.8859999775886536},{"id":"https://openalex.org/keywords/elderly-patients","display_name":"elderly patients","score":0.7360000014305115},{"id":"https://openalex.org/keywords/age-related-pharmacokinetic-changes","display_name":"age-related pharmacokinetics","score":0.5759999752044678},{"id":"https://openalex.org/keywords/cyp2c9","display_name":"CYP2C9","score":0.7450000047683716},{"id":"https://openalex.org/keywords/cyp3a4","display_name":"CYP3A4","score":0.996999979019165},{"id":"https://openalex.org/keywords/dose-reduction","display_name":"dose reduction","score":0.5460000038146973},{"id":"https://openalex.org/keywords/acute-coronary-syndrome","display_name":"acute coronary syndrome","score":0.9079999923706055},{"id":"https://openalex.org/keywords/physiologically-based-pharmacokinetic-model","display_name":"physiologically based pharmacokinetic modeling","score":0.7350000143051147}],"concepts":[{"id":"https://openalex.org/C2780499067","wikidata":"https://www.wikidata.org/wiki/Q415159","display_name":"Rosuvastatin","level":2,"score":0.9426000118255615},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.7975000143051147},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7682999968528748},{"id":"https://openalex.org/C2780890252","wikidata":"https://www.wikidata.org/wiki/Q420542","display_name":"Ticagrelor","level":4,"score":0.7555000185966492},{"id":"https://openalex.org/C185867374","wikidata":"https://www.wikidata.org/wiki/Q2562769","display_name":"Physiologically based pharmacokinetic modelling","level":3,"score":0.7318999767303467},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.5981000065803528},{"id":"https://openalex.org/C2908737378","wikidata":"https://www.wikidata.org/wiki/Q415159","display_name":"Rosuvastatin Calcium","level":3,"score":0.5916000008583069},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.590499997138977},{"id":"https://openalex.org/C2779384505","wikidata":"https://www.wikidata.org/wiki/Q17007513","display_name":"Concomitant","level":2,"score":0.5727999806404114},{"id":"https://openalex.org/C512196","wikidata":"https://www.wikidata.org/wiki/Q4650095","display_name":"Abcg2","level":5,"score":0.5418999791145325},{"id":"https://openalex.org/C19831878","wikidata":"https://www.wikidata.org/wiki/Q659446","display_name":"Therapeutic index","level":3,"score":0.44350001215934753},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.412200003862381},{"id":"https://openalex.org/C3946865","wikidata":"https://www.wikidata.org/wiki/Q5014962","display_name":"CYP2C9","level":4,"score":0.40299999713897705},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3799000084400177},{"id":"https://openalex.org/C2780272996","wikidata":"https://www.wikidata.org/wiki/Q1261151","display_name":"Therapeutic drug monitoring","level":3,"score":0.3743000030517578},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3409000039100647},{"id":"https://openalex.org/C2781190966","wikidata":"https://www.wikidata.org/wiki/Q420436","display_name":"Docetaxel","level":3,"score":0.32019999623298645},{"id":"https://openalex.org/C55775858","wikidata":"https://www.wikidata.org/wiki/Q1152227","display_name":"Pharmacogenetics","level":4,"score":0.2824000120162964},{"id":"https://openalex.org/C109650736","wikidata":"https://www.wikidata.org/wiki/Q424440","display_name":"CYP3A4","level":4,"score":0.27570000290870667},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.260699987411499},{"id":"https://openalex.org/C12174686","wikidata":"https://www.wikidata.org/wiki/Q1058438","display_name":"Risk assessment","level":2,"score":0.25949999690055847},{"id":"https://openalex.org/C33664856","wikidata":"https://www.wikidata.org/wiki/Q3271142","display_name":"CYP2D6","level":4,"score":0.25429999828338623}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.64898/2026.10.16.26365646","doi":"https://doi.org/10.64898/2026.10.16.26365646","is_oa":true,"landing_page_url":"https://doi.org/10.64898/2026.10.16.26365646","pdf_url":"https://www.medrxiv.org/content/medrxiv/early/2026/10/21/2026.10.16.26365646.full.pdf","source":{"id":"https://openalex.org/S3005729997","display_name":"medRxiv","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":["https://openalex.org/P4310315909"],"host_organization_lineage_names":["Cold Spring Harbor Laboratory Press"],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"medRxiv","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.64898/2026.10.16.26365646","doi":"https://doi.org/10.64898/2026.10.16.26365646","is_oa":true,"landing_page_url":"https://doi.org/10.64898/2026.10.16.26365646","pdf_url":"https://www.medrxiv.org/content/medrxiv/early/2026/10/21/2026.10.16.26365646.full.pdf","source":{"id":"https://openalex.org/S3005729997","display_name":"medRxiv","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":["https://openalex.org/P4310315909"],"host_organization_lineage_names":["Cold Spring Harbor Laboratory Press"],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"medRxiv","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320311904","display_name":"Wellcome Trust","ror":"https://ror.org/029chgv08"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7223093377.pdf","grobid_xml":"https://content.openalex.org/works/W7223093377.grobid-xml"},"referenced_works_count":28,"referenced_works":["https://openalex.org/W1996377151","https://openalex.org/W2002124497","https://openalex.org/W2038338711","https://openalex.org/W2080596408","https://openalex.org/W2086355748","https://openalex.org/W2141941946","https://openalex.org/W2156841554","https://openalex.org/W2159318213","https://openalex.org/W2164089346","https://openalex.org/W2166174569","https://openalex.org/W2522795135","https://openalex.org/W2765285908","https://openalex.org/W2767322095","https://openalex.org/W2799514315","https://openalex.org/W2935153017","https://openalex.org/W3036507987","https://openalex.org/W3136795133","https://openalex.org/W3207461217","https://openalex.org/W4213127162","https://openalex.org/W4292454430","https://openalex.org/W4311497617","https://openalex.org/W4317209295","https://openalex.org/W4367668438","https://openalex.org/W4387297230","https://openalex.org/W4402992598","https://openalex.org/W4407239213","https://openalex.org/W4408114082","https://openalex.org/W4413612932"],"related_works":["https://openalex.org/W2995315944","https://openalex.org/W4387297230","https://openalex.org/W4411111391","https://openalex.org/W2789460458","https://openalex.org/W1811890859","https://openalex.org/W4214528489","https://openalex.org/W7156684263","https://openalex.org/W2141941946","https://openalex.org/W7168172590","https://openalex.org/W2802832835"],"abstract_inverted_index":{"Abstract":[0],"Aims":[1],"Rosuvastatin":[2,121],"is":[3],"commonly":[4],"co-administered":[5],"with":[6,10,50,88,126,160,229],"ticagrelor":[7,51,71,133],"in":[8,52,76,104,169],"patients":[9,54,233],"acute":[11],"coronary":[12],"syndrome.":[13],"Ticagrelor":[14],"inhibits":[15],"breast":[16],"cancer":[17],"resistance":[18],"protein":[19],"(BCRP/ABCG2),":[20],"increasing":[21],"rosuvastatin":[22,48,69,166,227],"exposure":[23,123,136,189,204],"and":[24,38,70,74,86,101,106,135,155,224],"potentially":[25],"the":[26,39,161,165],"risk":[27,31],"of":[28,174],"rhabdomyolysis.":[29],"This":[30],"may":[32,234],"be":[33],"further":[34,237],"influenced":[35],"by":[36,56,119],"age":[37],"ABCG2":[40,57,92,225],"c.421C>A":[41,93],"variant.":[42],"We":[43],"aimed":[44],"to":[45,141,240],"predict":[46],"optimal":[47,143],"dosing":[49,228],"elderly":[53,84,195,210],"stratified":[55],"genotype":[58],"using":[59,78],"physiologically":[60],"based":[61],"pharmacokinetic":[62],"(PBPK)":[63],"modelling":[64,221],"Methods":[65],"PBPK":[66,147,220],"models":[67,148],"for":[68],"were":[72,109],"developed":[73],"validated":[75],"PK-Sim\u00ae":[77],"clinical":[79],"data":[80],"from":[81],"healthy":[82],"adults,":[83],"patients,":[85],"individuals":[87],"wild-type":[89,162,196,232],"or":[90,128],"homozygous":[91,182],"genotypes.":[94,156],"Key":[95],"parameters,":[96],"including":[97],"BCRP":[98,117],"catalytic":[99],"activity":[100],"age-dependent":[102],"declines":[103],"CYP2C9":[105],"CYP3A4":[107],"activity,":[108],"optimized.":[110],"The":[111,146],"drug\u2013drug":[112],"interaction":[113],"model":[114],"incorporated":[115],"competitive":[116],"inhibition":[118],"ticagrelor.":[120,230],"steady-state":[122],"was":[124,139],"simulated":[125],"half":[127],"quarter":[129],"standard":[130],"doses":[131],"during":[132],"co-administration,":[134],"matching":[137],"approach":[138],"used":[140],"identify":[142],"dosing.":[144],"Results":[145],"demonstrated":[149],"good":[150],"predictive":[151],"performance":[152],"across":[153],"populations":[154],"In":[157,180,194],"young":[158,181],"adults":[159],"genotype,":[163],"halving":[164],"dose":[167,200,238],"resulted":[168],"an":[170],"AUC":[171],"fold":[172,191,206],"change":[173,192,207],"1.44,":[175],"supporting":[176],"a":[177,198,215,236],"half-dose":[178,185,216],"strategy.":[179],"variant":[183,211],"carriers,":[184],"co-administration":[186],"produced":[187],"comparable":[188,203],"(AUC":[190,205],"0.78).":[193],"individuals,":[197],"four-fold":[199],"reduction":[201,217,239],"achieved":[202],"1.06),":[208],"whereas":[209],"carriers":[212],"required":[213],"only":[214],"(1.12).":[218],"Conclusions":[219],"supported":[222],"age-":[223],"genotype-specific":[226],"Elderly":[231],"require":[235],"minimise":[241],"toxicity":[242],"while":[243],"maintaining":[244],"therapeutic":[245],"exposure.":[246]},"counts_by_year":[],"updated_date":"2026-11-09T13:22:03.289127","created_date":"2026-10-22T00:00:00"}